Archives
Press Releases
advertisement
February 10, 2021
February 3, 2021
- Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care
- Roche Diabetes Care and Montméd join forces to bring Canadian led innovation to people living with diabetes
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (T1D)
- ViaCyte Announces Initiation of Phase 2 Study of Encapsulated Cell Therapy for Type 1 Diabetes Patients
January 6, 2021
- Routine eye scans may give clues to cognitive decline in diabetes
- Provention Bio Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
- Company expands recall of diabetes medication due to cancer-causing ingredient
December 30, 2020
December 16, 2020
- Xeris Pharmaceuticals Receives Positive CHMP Opinion for Ogluo™, Its Ready-To-Use (RTU) Glucagon for Injection, for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus
- Roche, Diabeloop partner on insulin pump management
- Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
advertisement
